SEC Form 4 · accession 0000899243-15-006567
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hansjoerg Wyss
10% Owner
Period of report
Oct 7, 2015
Accepted (ET)
Oct 9, 2015 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Oct 7, 2015 | C | 9,954,748 | — | A | 9,954,748 | D | |
| Ordinary SharesF2,F1 | Oct 7, 2015 | C | 825,649 | — | A | 10,780,397 | I | The Hansjoerg Wyss 2004 Descendants Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series I Convertible Preferred SharesF3,F2 | — | Oct 7, 2015 | C | 9,954,748 | D | — | — | Ordinary Shares | 9,954,748 | 0 | D |
| Series I Convertible Preferred SharesF3,F2,F1 | — | Oct 7, 2015 | C | 825,649 | D | — | — | Ordinary Shares | 825,649 | 0 | I |
Explanation of responses
- F1Mr. Wyss possesses no voting or investment power over shares held by The Hansjoerg Wyss 2004 Descendants Trust.
- F2N/A.
- F3Pursuant to the issuer's memorandum & articles of association, all outstanding preferred shares of each series automatically converted into ordinary shares upon consummation of the issuer's initial public offering on October 7, 2015.